Market Overview:
The Global Direct-to-Consumer (DTC) Genetic Testing Market was valued at USD 1.5 billion in 2021 and is projected to register a valuation of USD 4.1 billion by 2030, at a Compound Annual Growth Rate CAGR of 13.5% over the forecast period 2022-2030. The global market is growing, driven by increased awareness and emerging demand for consumer empowerment and fast, personalized services. However, companies offering these services face growing concerns over data confidentiality and scientific validity.
Genetic testing, also known as DNA testing, is used to identify changes in the DNA sequence or chromosome structure. Genetic testing may also include measuring the consequences of genetic changes, such as through RNA analysis, such as the production of gene expression, or through biochemical analysis to measure specific protein production.
In a medical setting, genetic testing may be used to diagnose or rule out suspected genetic disorders, predict risks for specific conditions, or obtain information that can be used to determine a person's genetics. Genetic testing can also be used to determine biological relatives, such as a child's parent i.e., genetic mother and father, through DNA paternity testing or an individual's pedigree.
Covid-19 Impact Analysis:
The outbreak of COVID-19 and the subsequent extent of the lockdown have impacted the direct-to-consumer genetic testing market across the globe. As the Covid-19 crisis continues, many global industrial manufacturing companies are facing challenging times, including production shutdowns, transportation, supply chain disruptions, cost increases, and workforce disruptions, which have several negative impacts on the global direct to consumer genetic testing industry in terms of revenue.
The COVID-19 pandemic positively impacted the direct-to-consumer genetic testing market. Amid the pandemic, technology improvements have paved the way for new business opportunities in direct-to-consumer genetic testing.
Driving Factors:
The increasing awareness among the general public about the availability of direct-to-consumer genetic tests in developed and developing countries will fuel the growth of the market over the anticipated timeline. The increasing demand for personalized direct-to-consumer genetic tests will drive market growth as customers are willing to pay to identify and address specific needs. The growing popularity of pharmacogenetics will also positively boost data from the direct-to-consumer genetic testing industry.
Restraining Factor:
There are certain hurdles and constraints to be faced which will hinder the overall market growth. DTC genetic testing raises a number of issues, including scientific, technical, and clinical issues, along with First Amendment issues of integrity, fidelity to facts, and truth in advertising. These are potential restrictions hindering the overall growth of the global market.
Key Market Players:
- 23andMe, Inc.
- EasyDNA
- Family Tree DNA
- Full Genome Corporation Inc.
- Ancestry
- Color Genomics
- Helix OpCo LLC
- Mapmygenome
- Identigene
- Pathway genomics
- Karmagenes SA
- Living DNA Ltd.
- Genesis Healthcare Co.
- The SkinDNA Company Pty Ltd
- MyHeritage
- 24 Genetics
- DNA Forensics Laboratory Pvt. Ltd.
- DNA Diagnostic Center
Market Segmentation:
The global direct to consumer genetic testing market is segmented by test type, technology, and region.
By Test Type
The ancestry & Relationship testing segment is expected to grow during the forecast period. People's growing interest in learning about their family tree and ancestors is anticipated to fuel the sale of ancestry tests in the future.
- Ancestry & Relationship Testing
- Nutrigenomic Testing
- Predictive Testing
- Carrier Testing
- Skincare Testing
By Technology
Among them, the whole genome sequencing segment is expected to dominate during the forecast period. Whole genome sequencing is one of the methods of analyzing the whole genome. This technique provides a high-resolution approach to genomic selection and helps to identify chromosomal regions associated with genetic influences on various traits.
- Single nucleotide polymorphism (SNP) chips
- Targeted Analysis
- Whole Genome Sequencing (WGS)
Regional Analysis:
The global direct-to-consumer genetic testing market is categorized into regions such as Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.
In North America, the U.S. holds the largest share in the year 2021 and is expected to continue to dominate the market over the forecast period. U.S. one of the largest and most competitive markets for direct-to-consumer genetic testing in the world. The presence of a large number of manufacturers is expected to lead to the production of relatively low cost units, which will boost the market. US And the high field growth in Canada is attributed to increased public awareness of direct-to-consumer genetic testing. Moreover, increasing internet usage among residences in dense regions of the country will positively improve the expansion of the market.
Report Coverage:
Market Segmentation:
By Type
- Ancestry & Relationship Testing
- Nutrigenomic Testing
- Predictive Testing
- Carrier Testing
- Skincare Testing
By Technology
- Single nucleotide polymorphism (SNP) chips
- Targeted Analysis
- Whole Genome Sequencing (WGS)
By Region
North America-
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa